Piper Jaffray Cuts Arena Pharma (ARNA) to Neutral
Tweet
Share
E-mail
Get Alerts ARNA Hot Sheet
Price: $99.98 --0%
Rating Summary:
10 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray's Edward Tenthoff downgraded shares of Arena Pharma (NASDAQ: ARNA) from Overweight to Neutral Wednesday morning. The analyst maintained a $2.50 price target.
The stock is down more than 4.5 percent in pre-market action. Shares last traded at $3.11.
For an analyst ratings summary and ratings history on Arena Pharma click here. For more ratings news on Arena Pharma click here.
The stock is down more than 4.5 percent in pre-market action. Shares last traded at $3.11.
For an analyst ratings summary and ratings history on Arena Pharma click here. For more ratings news on Arena Pharma click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
- UBS Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
